论文部分内容阅读
目的:观察在慢阻肺的急性加重期予以糖皮质激素、特布他林联合治疗的效果。方法:选取本院在2015年5月至2016年5月间所收治的慢阻肺急性加重期患者48例作为临床对象,随机分成对照组、观察组。对照组予以特布他林实现治疗,观察组予以糖皮质激素联合特布他林实现治疗,观察与比较临床疗效。结果:观察组总有效率明显比对照组高,且临床指标明显优于对照组。经统计学分析,存在着P<0.05的显著差异。结论:对于处于慢阻肺急性加重期患者予以糖皮质激素、特布他林联合治疗,效果比较显著,将患者的总有效率提升,将临床指标的水平优化,可以在临床上展开推广。
Objective: To observe the effect of glucocorticoid and terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: Forty-eight patients with COPD who were admitted to our hospital from May 2015 to May 2016 were randomly divided into control group and observation group. The control group was treated with terbutaline, the observation group was treated with glucocorticoid combined with terbutaline to observe and compare the clinical efficacy. Results: The total effective rate in the observation group was significantly higher than that in the control group, and the clinical indexes were significantly better than those in the control group. Statistically, there was a significant difference of P <0.05. Conclusion: The combination of glucocorticoid and terbutaline in patients with acute exacerbation of chronic obstructive pulmonary disease has a significant effect. The total effective rate of patients is improved. The level of clinical indicators is optimized and can be clinically promoted.